当前位置:首页 - 行情中心 - 金城医药(300233) - 财务分析 - 现金流量表

金城医药

(300233)

  

流通市值:63.67亿  总市值:65.76亿
流通股本:3.72亿   总股本:3.84亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,179,279,499.63578,120,274.52,930,947,832.982,256,659,030.64
  收到的税费返还6,006,474.872,878,811.4219,566,553.4216,551,341.21
  收到其他与经营活动有关的现金37,819,783.0717,515,968.4933,200,724.4543,617,201.89
  经营活动现金流入小计1,223,105,757.57598,515,054.412,983,715,110.852,316,827,573.74
  购买商品、接受劳务支付的现金457,323,403.98247,293,732.111,187,150,158.36906,924,467.08
  支付给职工以及为职工支付的现金339,477,303.84208,150,990.12626,189,540.81483,252,790.54
  支付的各项税费110,080,470.7749,828,338192,478,681.91155,200,017.4
  支付其他与经营活动有关的现金211,856,667.41101,807,386.13681,311,005.6570,011,475.9
  经营活动现金流出小计1,118,737,846607,080,446.362,687,129,386.682,115,388,750.92
  经营活动产生的现金流量净额104,367,911.57-8,565,391.95296,585,724.17201,438,822.82
二、投资活动产生的现金流量:
  取得投资收益收到的现金--323,349.14-
  处置固定资产、无形资产和其他长期资产收回的现金净额7,648,287.27,550,887.662,292,805.3358,334,706.37
  收到的其他与投资活动有关的现金490,799,553.67280,488,060.62349,827,811.99191,230,584.16
  投资活动现金流入小计498,447,840.87288,038,948.22412,443,966.46249,565,290.53
  购建固定资产、无形资产和其他长期资产支付的现金35,469,377.0517,561,108.78142,613,753.87112,037,743.27
  投资支付的现金--4,000,0004,000,000
  支付其他与投资活动有关的现金490,000,000280,000,000350,145,929.29240,437,500
  投资活动现金流出小计525,469,377.05297,561,108.78496,759,683.16356,475,243.27
  投资活动产生的现金流量净额-27,021,536.18-9,522,160.56-84,315,716.7-106,909,952.74
三、筹资活动产生的现金流量:
  吸收投资收到的现金--6,490,0003,540,000
  其中:子公司吸收少数股东投资收到的现金--6,490,0003,540,000
  取得借款收到的现金126,975,000108,000,000239,000,000190,000,000
  筹资活动现金流入小计126,975,000108,000,000245,490,000193,540,000
  偿还债务支付的现金269,245,193.26112,273,663.89280,782,961.02148,582,244.35
  分配股利、利润或偿付利息支付的现金120,109,129.5560,229,300.44150,868,869.9143,479,463.76
  其中:子公司支付给少数股东的股利、利润--19,198,20015,358,560
  支付其他与筹资活动有关的现金1,161,908958,33457,609,074.7457,097,329.18
  筹资活动现金流出小计390,516,230.81173,461,298.33489,260,905.66349,159,037.29
  筹资活动产生的现金流量净额-263,541,230.81-65,461,298.33-243,770,905.66-155,619,037.29
四、汇率变动对现金及现金等价物的影响1,867,868.361,463,5855,963,880.284,242,300.79
五、现金及现金等价物净增加额-184,326,987.06-82,085,265.84-25,537,017.91-56,847,866.42
  加:期初现金及现金等价物余额878,484,110.4878,484,110.4904,021,128.31904,021,128.31
  期末现金及现金等价物余额694,157,123.34796,398,844.56878,484,110.4847,173,261.89
补充资料:
  净利润44,966,077.75-207,735,344.13-
  资产减值准备8,134,729.93-31,237,432.35-
  固定资产和投资性房地产折旧123,515,309.38-248,285,236.01-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧123,515,309.38-248,285,236.01-
  无形资产摊销32,791,304.13-68,554,555.18-
  长期待摊费用摊销1,613,648.67-3,506,502.94-
  处置固定资产、无形资产和其他长期资产的损失-388,847.35--1,454,864.3-
  固定资产报废损失-80,388.22--98,723.86-
  公允价值变动损失143,866.15--86,537.6-
  财务费用4,271,753.33-12,514,185.31-
  投资损失-967,435.41-1,665,130.72-
  递延所得税78,681.93-3,108,185.81-
  其中:递延所得税资产减少11,188,046.9-5,836,011.1-
    递延所得税负债增加-11,109,364.97--2,727,825.29-
  存货的减少-15,060,506.46--115,589,406.28-
  经营性应收项目的减少106,942,546.84--28,107,015.69-
  经营性应付项目的增加-194,049,412.22--137,105,665.96-
  现金的期末余额694,157,123.34-878,484,110.4-
  减:现金的期初余额878,484,110.4-904,021,128.31-
  现金及现金等价物的净增加额-184,326,987.06--25,537,017.91-
公告日期2025-08-212025-04-292025-03-282024-10-25
审计意见(境内)标准无保留意见
TOP↑